🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ruixia Ma

InterDigital (United States)

ORCID: 0000-0002-5492-2575

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Structure-activity relationship studies on O-alkylamino-tethered salicylamide derivatives with various amino acid linkers as potent anticancer agents”.

Structure-activity relationship studies on O-alkylamino-tethered salicylamide derivatives with various amino acid linkers as potent anticancer agents

European Journal of Medicinal Chemistry(2022)10.1016/j.ejmech.2022.114229

N/A

0DataRank · unranked

4 citations

Hye-Jin Kim, Jiabin Dong, Haiying Chen, Junhai Xu, Ruixia Ma +5 more

Sulindac sulfide suppresses oncogenic transformation through let-7b-mediated repression of K-Ras signaling

Cell Death Discovery(2025)10.1038/s41420-025-02858-2

N/A

0DataRank · unranked

1 citations

Ruixia Ma, Bin Yi, Adam I. Riker, Yaguang Xi, Zhipin Liang

Sulindac modulates the response of triple negative breast cancer to anti-PD-L1 immunotherapy

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.11.659159

N/A

0DataRank · unranked

0 citations

Ruixia Ma, Xin Zhang, Li Li, Adam I. Riker, Yaguang Xi +1 more